Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...
The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...
People will no longer be able to get weight-loss jabs after completing a simple online questionnaire as the pharmacy regulator ... to make sure jabs such as Wegovy or Mounjaro are prescribed ...
More and more people are taking weight loss injectables like Wegovy and Mounjaro — and though the drugs are gaining credibility when used properly, pharmacy experts are worried that not everyone ...
Prescription data from IQVIA suggests Novo's obesity drug Wegovy is losing ground to rival ... Novo's 2025 sales guidance implies a 30% increase in the number of patients taking one of the ...
Weight loss jabs were originally approved just for Type 2 diabetes but versions such as Wegovy and Mounjaro are ... "We know online pharmacy services can provide a very valuable service, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results